Clinical trial

Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy

NCT06713720

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-04-20

PhaseNA

Study timeline

Study start (actual)2025-04-20Date precision: day

Registry last updated2025-06-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Retinopathyverified · MONDO: diabetic retinopathy

Non-Proliferative Diabetic Retinopathyverified · MONDO: background diabetic retinopathy

Remote Ischemic Conditioningunresolved

Diabetes Mellitus, Type 2verified · MONDO: type 2 diabetes mellitus

Randomized Controlled Trialunresolved

Interventions

Remote Ischemic Conditioning DeviceDEVICE

Sham Remote Ischemic Conditioning DeviceDEVICE

Sponsors & collaborators

Xuxiang Zhang, MDlead sponsor

Xuanwu Hospital, Beijingcollaborator

Mapped research locations

BeijingBeijing Municipality, China2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06713720 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.